|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1600 - 0.1600|
|52 Week Range||0.0500 - 0.3900|
|Beta (5Y Monthly)||-1.70|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CLEVELAND, OH / ACCESSWIRE / March 23, 2020 / Innovest Global Inc. (IVST), a diversified industrials company with a pending spinout of its biotechnology holdings, today provided an update on business operations in light of the recent COVID-19 pandemic. In 2017, just three years ago, Innovest was founded with the mindset to turn-around a distressed public company into a scalable industrials company. Innovest's goal was to enhance shareholder value by acquiring companies on favorable terms and achieving organic growth.
CLEVELAND, OH / ACCESSWIRE / March 3, 2020 / Innovest Global Inc. (OTC PINK:IVST), a diversified industrials company, has completed the acquisition of 100% interest in StemVax Therapeutics, a biotechnology company developing novel therapies for brain tumor patients. Since acquiring a 20% interest in StemVax in July 2018, Innovest has developed its biotech division to rapidly accelerate research and development to successfully bring safe and efficacious novel immunotherapeutics to market.
Management to Showcase New Investor Presentation & Business Model During Online Event CLEVELAND, OH / ACCESSWIRE / February 25, 2020 / Innovest Global, Inc. (OTC: IVST ), a diversified industrials company ...
CLEVELAND, OH / ACCESSWIRE / February 12, 2020 / Innovest Global Inc. (OTCPINK:IVST), a diversified industrials company, has engaged international investor relations specialists MZ Group (MZ) to lead a ...